Literature DB >> 24220851

Enhancement of expression of survivin promoter-driven CD/TK double suicide genes by the nuclear matrix attachment region in transgenic gastric cancer cells.

Ying Niu1, Jian-Sheng Li2, Xian-Run Luo3.   

Abstract

This work aimed to study a novel transgenic expression system of the CD/TK double suicide genes enhanced by the nuclear matrix attachment region (MAR) for gene therapy. The recombinant vector pMS-CD/TK containing the MAR-survivin promoter-CD/TK cassette was developed and transfected into human gastric cancer SGC-7901 cells. Expression of the CD/TK genes was detected by quantitative real-time PCR (qPCR) and Western blot. Cell viability and apoptosis were measured using the methyl thiazolyl tetrazolium (MTT) assay and flow cytometry. When the MAR fragment was inserted into the upstream of the survivin promoter, the qPCR result showed that the expression of the CD/TK genes significantly increased 7.7-fold in the transgenic SGC-7901 cells with plasmid pMS-CD/TK compared with that without MAR. MTT and flow cytometry analyses indicated that treatment with the prodrugs (5-FC+GCV) significantly decreased the cellular survival rate and enhanced the cellular apoptosis in the SGC-7901 cells. The expression of the CD/TK double suicide genes driven by the survivin promoter can be enhanced by the MAR fragment in human gastric cancer cells.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-FC; 5-fluorocytosine; CD; Ct; DMEM; Dulbecco's modified Eagle's Medium; GCV; Gastric cancer; Gene therapy; MAR; MTT; Matrix attachment region; PCR; PI; Suicide gene; Survivin promoter; TK; cytosine deaminase; ganciclovir; matrix attachment region; methyl thiazolyl tetrazolium; polymerase chain reaction; propidium iodide; qPCR; quantitative real-time PCR; threshold cycle number; thymidine kinase

Mesh:

Substances:

Year:  2013        PMID: 24220851     DOI: 10.1016/j.gene.2013.10.064

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer.

Authors:  Ana Rosa Rama Ballesteros; Rosa Hernández; Gloria Perazzoli; Laura Cabeza; Consolación Melguizo; Celia Vélez; Jose Prados
Journal:  Cancer Gene Ther       Date:  2019-09-24       Impact factor: 5.987

2.  A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy.

Authors:  Yoon Khei Ho; Jun Yung Woo; Geraldine Xue En Tu; Lih-Wen Deng; Heng-Phon Too
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

3.  Enhancement of nanoparticle-mediated double suicide gene expression driven by 'E9-hTERT promoter' switch in dedifferentiated thyroid cancer cells.

Authors:  Aoshuang Chang; Junjun Ling; Huiping Ye; Houyu Zhao; Xianlu Zhuo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.